business
Popular antidepressant recalled over high levels of a cancer-causing compound
By Danielle Abreu at NBC 5 Dallas-Fort Worth (KXAS)
· June 19, 2026
· 1 min read
A popular antidepressant is being recalled because they may contain high levels of a cancer-causing compound.
The New-Jersey based drug company Breckenridge Pharmaceuticals is recalling bottles of the prescription drug duloxetine, a generic version of Cymbalta. The medication is used to treat ...
Key takeaway The 30mg capsules recalled have an expiration date of April 2027 and Lot code 241180C, according to the FDA.
Why this matters in The Trophy Club
For residents of Trophy Club , the recall of duloxetine delayed-release capsules raises concerns about the safety of medications prescribed by local healthcare providers. Patients who take this generic version of Cymbalta for depression, anxiety, or fibromyalgia should check their medication bottles for the recalled lot numbers and expiration dates. The recall affects not only individuals but also local pharmacies and medical offices that may have distributed the medication. Trophy Club residents who are affected by the recall will need to contact their doctors or pharmacists to discuss alternative treatment options, ensuring continuity of care and minimizing potential health risks. The local healthcare community will likely be monitoring the situation closely, providing guidance to patients and implementing measures to prevent similar incidents in the future. As the recall unfolds, it will be important to track how local healthcare providers and pharmacies respond to the recall and support their patients.
About this story
Original reporting by NBC 5 Dallas-Fort Worth (KXAS) . The Trophy Club surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC 5 Dallas-Fort Worth (KXAS) . Have a tip or correction? Contact our newsroom .
Category: business ·
Published: June 19, 2026 ·
Source: NBC 5 Dallas-Fort Worth (KXAS) ·
Reading time: 1 min
Get more The Trophy Club stories like this
Free weekly briefing covering business and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? A popular antidepressant is being recalled because they may contain high levels of a cancer-causing compound.
The New-Jersey based drug company Breckenridge Pharmaceuticals is recalling bottles of the prescription drug duloxetine, a generic version of Cymbalta. The medication is used to treat ...
When was this published? This article was first published on June 19, 2026 by NBC 5 Dallas-Fort Worth (KXAS) and curated for The Trophy Club readers.
Who reported this story? This story was reported by Danielle Abreu at NBC 5 Dallas-Fort Worth (KXAS). To learn more about how The Trophy Club selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more business coverage from The Trophy Club, or browse our daily briefing and topic hubs .
← Back to all news
More business →
Today’s briefing
Subscribe to newsletter